While further validation studies are mandatory to assess the sensitivity and specificity of ITM2B, GRN and PSAP as uEV biomarkers, these early results highlight the promise of our approach for a GBM liquid gold biopsy. The gene discussed is GRN; the disease is glioblastoma.